Story perspectives
AI in Cancer Pathology: Misleading Shortcuts Raise Concerns
3/3/2026
1 of 1
Story summary
- The University of Warwick study finds AI in cancer pathology relies on misleading shortcuts rather than biological signals, undermining reliability.
- Analyzing data from 8,000+ patient samples, researchers show AI tools achieve high accuracy by exploiting correlations, such as predicting BRAF mutations from microsatellite instability (MSI).
- This reliance on indirect measures raises concerns about AI models' clinical usefulness.
- The study urges stricter evaluation and a shift to causal, biology-aware AI.
